SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022987
Filing Date
2021-05-04
Accepted
2021-05-04 07:15:41
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glto-10q_20210331.htm 10-Q 1348581
2 EX-31.1 glto-ex311_7.htm EX-31.1 25255
3 EX-31.2 glto-ex312_8.htm EX-31.2 25013
4 EX-32.1 glto-ex321_6.htm EX-32.1 16943
  Complete submission text file 0001564590-21-022987.txt   4864376

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glto-20210331.xml EX-101.INS 960636
6 XBRL TAXONOMY EXTENSION SCHEMA glto-20210331.xsd EX-101.SCH 36384
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glto-20210331_cal.xml EX-101.CAL 46505
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glto-20210331_def.xml EX-101.DEF 76201
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glto-20210331_lab.xml EX-101.LAB 304611
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glto-20210331_pre.xml EX-101.PRE 228754
Mailing Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200
Business Address GALECTO BIOTECH AB OLE MAALOES VEJ3 COPENHAGEN G7 DK-2200 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39655 | Film No.: 21885980
SIC: 2834 Pharmaceutical Preparations